(en) Levy HB, Kohlhaas HK. Considerations for supplementing with coenzyme Q10 during statin therapy. 2006. Ann Pharmacother 40:290-294. DOI: 10.1345/aph.1G409PMID16449543
(en) Hosoe, K., & Funahashi, I. (2022). Lower plasma coenzyme Q10 concentrations in healthy vegetarians and vegans compared with omnivores. International Journal on Nutraceuticals, Functional Foods and Novel Foods. 379-386. DOI:10.17470/NF-022-0047.
(en) Folkers K, Langsjoen P, Willis R, et al. Lovastatin decreases coenzyme Q levels in humans. 1990. Proc Natl Acad Sci U S A 87:8931-8934. PMID2247468gratis volledige artikel
(en) Langsjoen PH, Langsjoen AM. The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications. 2003. Biofactors 18:101-111. PMID14695925
(en) Hargreaves IP, Duncan AJ, Heales SJ, et al. The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications. 2005. Drug Saf 28:659-676. PMID16048353
(en) Passi S, Stancato A, Aleo E, et al. Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA. 2003. Biofactors 18:113-124. PMID14695926
(en) Levy HB, Kohlhaas HK. Considerations for supplementing with coenzyme Q10 during statin therapy. 2006. Ann Pharmacother 40:290-294. DOI: 10.1345/aph.1G409PMID16449543
(en) Langsjoen PH, Langsjoen JO, Langsjoen AM, et al. Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation. 2005. Biofactors 25:147-152. PMID16873939
